Co-reporter:Hiroyuki Kobayashi, Takashi Misawa, Kenji Matsuno, and Yosuke Demizu
The Journal of Organic Chemistry October 6, 2017 Volume 82(Issue 19) pp:10722-10722
Publication Date(Web):September 15, 2017
DOI:10.1021/acs.joc.7b01946
Preorganized cyclic α,α-disubstituted α-amino acids (dAA) bearing functionalized side chains that acted as peptide-helix inducers, which could be used for solid-phase peptide synthesis, were designed and synthesized. Furthermore, a helical octapeptide with the following amino acid sequence was prepared, and its preferred conformation was analyzed based on its CD spectra: Ac-X1EYSAX2KA-NH2 (11: X1 = ApiC4N3, X2 = Ac6c). The side-chain azido functional group of peptide 11 was efficiently converted to various 1,2,3-triazole groups via Huisgen 1,3-dipolar cycloaddition reactions involving different types of alkynes. The new cyclic dAA derivatives, which combine the advantages of conformational preorganization and side-chain functional groups, should prove to be a useful tool for the further development of biologically active peptides.
Co-reporter:Takashi Misawa, Yasunari Kanda, and Yosuke Demizu
Bioconjugate Chemistry December 20, 2017 Volume 28(Issue 12) pp:3029-3029
Publication Date(Web):November 14, 2017
DOI:10.1021/acs.bioconjchem.7b00621
In this study, we developed post-functionalizable helical peptides composed of Leu, Aib, and Azl residues. We show that the synthesized peptides 1 and 2 form helical structures, and may be modified using specific side chain or several functional groups by the click reaction without influencing their secondary structures.
Co-reporter:Takayuki Hattori, Koyo Okitsu, Norikazu Yamazaki, Nobumichi Ohoka, Norihito Shibata, Takashi Misawa, Masaaki Kurihara, Yosuke Demizu, Mikihiko Naito
Bioorganic & Medicinal Chemistry Letters 2017 Volume 27, Issue 18(Issue 18) pp:
Publication Date(Web):15 September 2017
DOI:10.1016/j.bmcl.2017.08.001
We designed and synthesized hybrid molecules for a protein knockdown method based on the recognition of a His-tag fused to a protein of interest (POI). The synthesized target protein degradation inducers contained three functional moieties: a His-tag ligand (nickel nitrilotriacetic acid [Ni-NTA]), an E3 ligand (bestatin [BS] or MV1), and a carrier peptide (Tat or nonaarginine [R9]). The designed hybrid molecules, BS-Tat-Ni-NTA, MV1-Tat-Ni-NTA, BS-R9-Ni-NTA, and MV1-R9-Ni-NTA, efficiently degraded His-tagged cellular retinoic acid binding protein 2 via the ubiquitin–proteasome system (UPS). This system will become a useful tool for research into selective protein degradation inducers that act via the UPS.Download high-res image (158KB)Download full-size image
Co-reporter:Nobumichi Ohoka, Takashi Misawa, Masaaki Kurihara, Yosuke Demizu, Mikihiko Naito
Bioorganic & Medicinal Chemistry Letters 2017 Volume 27, Issue 22(Issue 22) pp:
Publication Date(Web):15 November 2017
DOI:10.1016/j.bmcl.2017.10.011
We previously developed a protein knockdown system by small-molecule hybrid compounds named SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers). Here we report a peptide-based protein knockdown system for inducing degradation of a transcriptional factor NOTCH1. The molecules designed were composed of two biologically active scaffolds: a peptide that binds to the surface of the target protein NOTCH1 and a small-molecule MV1 that binds to the E3 ubiquitin ligase inhibitor of apoptosis protein (IAP), which are expected to cross-link these proteins in cells. Hybrid molecules specifically induced the degradation of the NOTCH1 protein by the proteasome. This system could be a useful method to develop various degradation inducers against a large number of proteins to which small-molecule ligands have not been found.Download high-res image (104KB)Download full-size image
Co-reporter:Koyo Okitsu, Takashi Misawa, Takuji Shoda, Masaaki Kurihara, Yosuke Demizu
Bioorganic & Medicinal Chemistry Letters 2017 Volume 27, Issue 15(Issue 15) pp:
Publication Date(Web):1 August 2017
DOI:10.1016/j.bmcl.2017.05.087
The fluorescent labeling of target proteins is useful for analyzing their functions and localization in cells, and several fluorescent probes have been developed. However, the fusion of tags such as green fluorescent protein (GFP) to target proteins occasionally affects their functions and/or localization in living cells. Therefore, an imaging method that uses short peptide tags such as hexa-histidine (the His tag) has been attracting increasing attention. Few studies have investigated ON/OFF switchable fluorescent probes for intracellular His-tagged proteins. We herein developed a novel ON/OFF switchable probe for imaging targeted intracellular proteins fused with a CH6 tag, which is composed of one cysteine residue and six histidine residues.Download high-res image (107KB)Download full-size image
Co-reporter:Takashi Misawa, Mitsuyoshi Imamura, Yuto Ozawa, Kazuchika Haishima, Masaaki Kurihara, Yutaka Kikuchi, Yosuke Demizu
Bioorganic & Medicinal Chemistry Letters 2017 Volume 27, Issue 17(Issue 17) pp:
Publication Date(Web):1 September 2017
DOI:10.1016/j.bmcl.2017.07.074
Lysine-based amphipathic nonapeptides, including homochiral peptides [Ac-(l-Lys-l-Lys-Xaa)3-NH2 (Xaa = Gly, Ala, Aib, Ac5c, or Ac6c) and Ac-(d-Lys-d-Lys-Aib)3-NH2], a heterochiral peptide [Ac-(l-Lys-d-Lys-Aib)3-NH2], and a racemic mixture of diastereomeric peptides [Ac-(rac-Lys-rac-Lys-Aib)3-NH2] were designed and synthesized to investigate the relationship between their preferred secondary structures and their antimicrobial activity. Peptide 5, [Ac-(l-Lys-l-Lys-Ac6c)3-NH2] formed a stable α-helical structure and exhibited strong activity against Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa).Download high-res image (145KB)Download full-size image
Co-reporter:Yosuke Demizu;Hiroko Yamashita;Takashi Misawa;Mitsunobu Doi;Makoto Oba;Masakazu Tanaka;Masaaki Kurihara
European Journal of Organic Chemistry 2016 Volume 2016( Issue 4) pp:840-846
Publication Date(Web):
DOI:10.1002/ejoc.201501146
Abstract
A homochiral L-Leu-L-Leu-Aib segment was incorporated into the N- or C-termini of left-handed (M) helical peptides (D-Leu-L-Leu-Aib)n. We then investigated the preferred conformations of two sets of three peptides; i.e., Boc-L-Leu-L-Leu-Aib-(D-Leu-L-Leu-Aib)n-OMe (n = 1: 1; 2: 2; 3: 3) and Boc-(D-Leu-L-Leu-Aib)n-L-Leu-L-Leu-Aib-OMe (n = 1: 4; 2: 5; 3: 6), in solution and in the crystalline state. Nonapeptide 2 and dodecapeptide 3, each containing an N-terminal L-Leu-L-Leu-Aib segment, formed left-handed (M) helices as the preferred secondary structures in solution. In the crystalline state, nonapeptide 2 folded into an (M) α-helical structure. Peptides 4–6, each containing a C-terminal L-Leu-L-Leu-Aib segment, formed roughly equivalent amounts of right-handed (P) and (M) helices.
Co-reporter:Takuma Kato, Hiroko Yamashita, Takashi Misawa, Koyo Nishida, Masaaki Kurihara, Masakazu Tanaka, Yosuke Demizu, Makoto Oba
Bioorganic & Medicinal Chemistry 2016 Volume 24(Issue 12) pp:2681-2687
Publication Date(Web):15 June 2016
DOI:10.1016/j.bmc.2016.04.031
Cell-penetrating peptides (CPPs) have been developed as drug, protein, and gene delivery tools. In the present study, arginine (Arg)-rich CPPs containing unnatural amino acids were designed to deliver plasmid DNA (pDNA). The transfection ability of one of the Arg-rich CPPs examined here was more effective than that of the Arg nonapeptide, which is the most frequently used CPP. The transfection efficiencies of Arg-rich CPPs increased with longer post-incubation times and were significantly higher at 48-h and 72-h post-incubation than that of the commercially available transfection reagent TurboFect. These Arg-rich CPPs were complexed with pDNA for a long time in cells and effectively escaped from the late endosomes/lysosomes into the cytoplasm. These results will be helpful for designing novel CPPs for pDNA delivery.
Co-reporter:Yosuke Demizu, Norihito Shibata, Takayuki Hattori, Nobumichi Ohoka, Hiromi Motoi, Takashi Misawa, Takuji Shoda, Mikihiko Naito, Masaaki Kurihara
Bioorganic & Medicinal Chemistry Letters 2016 Volume 26(Issue 20) pp:4865-4869
Publication Date(Web):15 October 2016
DOI:10.1016/j.bmcl.2016.09.041
The manipulation of protein stability with small molecules has great potential as a technique for aiding the development of clinical therapies, including treatments for cancer. In this study, BCR-ABL protein degradation inducers called SNIPER(ABL) (Specific and Non-genetic inhibitors of apoptosis protein [IAP]-dependent Protein Erasers) were developed. The designed molecules contained two biologically active scaffolds: one was an imatinib derivative that binds to BCL-ABL and the other was a methyl bestatin that binds to cellular IAP 1 (cIAP1). The hybrid molecules, SNIPER(ABL), were expected to recruit BCR-ABL to cIAP1 for removal by proteasomes. In fact, SNIPER(ABL) induced the degradation of BCR-ABL protein and a subsequent reduction in cell growth. Thus, the degradation of BCR-ABL by SNIPER(ABL) is one potential strategy for treating BCR-ABL driven chronic myelogenous leukemia.
Co-reporter:Hiroko Yamashita; Makoto Oba;Dr. Takashi Misawa; Masakazu Tanaka;Dr. Takayuki Hattori;Dr. Mikihiko Naito;Dr. Masaaki Kurihara;Dr. Yosuke Demizu
ChemBioChem 2016 Volume 17( Issue 2) pp:137-140
Publication Date(Web):
DOI:10.1002/cbic.201500468
Abstract
Two types of cationic cyclic α,α-disubstituted α-amino acids: Api (which possesses a lysine mimic side chain) and ApiC2Gu (which possesses an arginine mimic side chain), were developed. These amino acids were incorporated into an arginine-based peptide sequence [(l-Arg-l-Arg-dAA)3: dAA=Api or ApiC2Gu], and the relationship between the secondary structures of the resulting peptides and their ability to pass through cell membranes was investigated. The peptide containing ApiC2Gu formed a stable α-helical structure and was more effective at penetrating cells than the nonhelical Arg nonapeptide (R9). Furthermore, the peptide was able to deliver plasmid DNA into various types of cells in a highly efficient manner.
Co-reporter:Hiroko Yamashita; Makoto Oba;Dr. Takashi Misawa; Masakazu Tanaka;Dr. Takayuki Hattori;Dr. Mikihiko Naito;Dr. Masaaki Kurihara;Dr. Yosuke Demizu
ChemBioChem 2016 Volume 17( Issue 2) pp:
Publication Date(Web):
DOI:10.1002/cbic.201500677
Co-reporter:Yosuke Demizu, Nobumichi Ohoka, Takaya Nagakubo, Hiroko Yamashita, Takashi Misawa, Keiichiro Okuhira, Mikihiko Naito, Masaaki Kurihara
Bioorganic & Medicinal Chemistry Letters 2016 26(11) pp: 2655-2658
Publication Date(Web):1 June 2016
DOI:10.1016/j.bmcl.2016.04.013
A peptide-based protein knockdown system for inducing nuclear receptors degradation via the ubiquitin–proteasome system was developed. Specifically, the designed molecules were composed of two biologically active scaffolds: a peptide that binds to the estrogen receptor α (ERα) surface and an MV1 molecule that binds to cellular inhibitors of apoptosis proteins (IAP: cIAP1/cIAP2/XIAP) to induce ubiquitylation of the ERα. The hybrid peptides induced IAP-mediated ubiquitylation followed by proteasomal degradation of the ERα. Those peptides were also applicable for inducing androgen receptor (AR) degradation.
Co-reporter:Yosuke Demizu, Makoto Oba, Koyo Okitsu, Hiroko Yamashita, Takashi Misawa, Masakazu Tanaka, Masaaki Kurihara and Samuel H. Gellman
Organic & Biomolecular Chemistry 2015 vol. 13(Issue 20) pp:5617-5620
Publication Date(Web):14 Apr 2015
DOI:10.1039/C5OB00389J
A cyclic β-amino acid (APCGu) bearing a side-chain guanidinium group has been developed. The APCGu residue was incorporated into an α/β-peptide based on the Tat(47–57) fragment, leading to an oligomer with substantial helicity in methanol that enters HeLa cells much more readily than does the corresponding Tat α-peptide.
Co-reporter:Yosuke Demizu, Hiroko Yamashita, Mitsunobu Doi, Takashi Misawa, Makoto Oba, Masakazu Tanaka, and Masaaki Kurihara
The Journal of Organic Chemistry 2015 Volume 80(Issue 17) pp:8597-8603
Publication Date(Web):August 14, 2015
DOI:10.1021/acs.joc.5b01541
We designed and synthesized two dodecapeptides, Boc-(l-Leu-l-Leu-Aib-d-Leu-d-Leu-Aib)2-OMe (5) and Boc-l-Leu-l-Leu-Aib-(d-Leu-d-Leu-Aib)2-l-Leu-l-Leu-Aib-OMe (6), that contain equal amounts of l-Leu, d-Leu, and achiral Aib residues. The conformations of peptides 5 and 6 in the crystalline state were studied using X-ray crystallographic analysis. Peptide 5 formed a left-handed (M) α-helical structure, whereas peptide 6 was composed of a combination of fused (M) α-helical and right-handed (P) 310-helical structures. In solution, roughly equivalent amounts of (P) and (M) helices were present in 5, whereas the (M) α-helix was present in 6 as its dominant conformation.
Co-reporter:Hiroko Yamashita, Yosuke Demizu, Takashi Misawa, Takuji Shoda, Masaaki Kurihara
Tetrahedron 2015 Volume 71(Issue 15) pp:2241-2245
Publication Date(Web):15 April 2015
DOI:10.1016/j.tet.2015.02.076
A new bis-cationic cyclic amino acid, 9-amino-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid (9-amino-bispidine-9-carboxylic acid; Abp), which is available for both solution phase and solid phase peptide synthesis, was designed and synthesized. Furthermore, a heterotripeptide Cbz-Leu-Abp-Ala-OMe (9) containing Abp was prepared, and its dominant conformation was analyzed by examining its nuclear magnetic resonance and infrared spectra and performing molecular modeling. The tripeptide 9 formed a β-turn structure as its preferred conformation in solution.
Co-reporter:Takashi Misawa, Yosuke Demizu, Megumi Kawamura, Nanako Yamagata, Masaaki Kurihara
Bioorganic & Medicinal Chemistry 2015 23(5) pp: 1055-1061
Publication Date(Web):
DOI:10.1016/j.bmc.2015.01.007
Co-reporter:Yosuke Demizu, Takashi Misawa, Takaya Nagakubo, Yasunari Kanda, Keiichiro Okuhira, Yuko Sekino, Mikihiko Naito, Masaaki Kurihara
Bioorganic & Medicinal Chemistry 2015 23(15) pp: 4132-4138
Publication Date(Web):
DOI:10.1016/j.bmc.2015.06.067
Co-reporter:Takaya Nagakubo, Yosuke Demizu, Yasunari Kanda, Takashi Misawa, Takuji Shoda, Keiichiro Okuhira, Yuko Sekino, Mikihiko Naito, and Masaaki Kurihara
Bioconjugate Chemistry 2014 Volume 25(Issue 11) pp:1921
Publication Date(Web):November 6, 2014
DOI:10.1021/bc500480e
The heptaarginine (R7)-conjugated peptide 5 was designed and synthesized as an inhibitor of ER-coactivator interactions and ER-mediated transcription at the cellular level. The R7-conjugated peptide 5 was able to enter ER-positive T47D cells efficiently, and treatment with 3 μM of 5 downregulated the mRNA expression of pS2 (an ER-mediated gene) by 87%.
Co-reporter:Hiroko Yamashita, Yosuke Demizu, Takuji Shoda, Yukiko Sato, Makoto Oba, Masakazu Tanaka, Masaaki Kurihara
Bioorganic & Medicinal Chemistry 2014 Volume 22(Issue 8) pp:2403-2408
Publication Date(Web):15 April 2014
DOI:10.1016/j.bmc.2014.03.005
We synthesized four types of arginine-based amphipathic nonapeptides, including two homochiral peptides, R-(l-Arg-l-Arg-Aib)3-NH2 (R = 6-FAM-β-Ala: FAM-1; R = Ac: Ac-1) and R-(d-Arg-d-Arg-Aib)3-NH2 (R = 6-FAM-β-Ala: ent-FAM-1; R = Ac: ent-Ac-1); a heterochiral peptide, R-(l-Arg-d-Arg-Aib)3-NH2 (R = 6-FAM-β-Ala: FAM-2; R = Ac: Ac-2); and a racemic mixture of diastereomeric peptides, R-(rac-Arg-rac-Arg-Aib)3-NH2 (R = 6-FAM-β-Ala: FAM-3; R = Ac: Ac-3), and then investigated the relationship between their secondary structures and their ability to pass through cell membranes. Peptides 1 and ent-1 formed stable one-handed α-helical structures and were more effective at penetrating HeLa cells than the non-helical peptides 2 and 3.
Co-reporter:Yosuke Demizu, Saori Nagoya, Manami Shirakawa, Megumi Kawamura, Nanako Yamagata, Yukiko Sato, Mitsunobu Doi, Masaaki Kurihara
Bioorganic & Medicinal Chemistry Letters 2013 Volume 23(Issue 15) pp:4292-4296
Publication Date(Web):1 August 2013
DOI:10.1016/j.bmcl.2013.06.002
We synthesized stapled helical leucine-based peptides (DPI-01-07) containing 2-aminoisobutyric acid and a covalent cross-linked unit as inhibitors of vitamin D receptor (VDR)–coactivator interactions. The effects of these peptides on the human VDR were examined in an inhibition assay based on the receptor cofactor assay system, and one of them, DPI-07, exhibited potent inhibitory activity (IC50: 3.2 μM).
Co-reporter:Norikazu Yamazaki, Yosuke Demizu, Yukiko Sato, Mitsunobu Doi, and Masaaki Kurihara
The Journal of Organic Chemistry 2013 Volume 78(Issue 19) pp:9991-9994
Publication Date(Web):August 19, 2013
DOI:10.1021/jo401505b
We have developed new helical oligomers using a combination of (1S,2S)-cyclopentane-1,2-diamine [(S,S)-CPDA] and 2,2-dimethylmalonic acid (DMM) residues as building blocks. In solution, the preferred secondary structure of the (S,S) tetramer 6 was a right-handed (P) helix, and that of the (R,R) tetramer ent-6 was a left-handed (M) helix. In the crystalline state, both 6 and the (S,S) pentamer 7 folded into (P) 11-helices, and ent-6 folded into an (M) 11-helix with hydrogen bonds that were oriented in alternating directions.
Co-reporter:Yosuke Demizu, Hiroko Yamashita, Norikazu Yamazaki, Yukiko Sato, Mitsunobu Doi, Masakazu Tanaka, and Masaaki Kurihara
The Journal of Organic Chemistry 2013 Volume 78(Issue 23) pp:12106-12113
Publication Date(Web):November 5, 2013
DOI:10.1021/jo402133e
We investigated the preferred conformations of two nonapeptides, Boc-(l-Leu-d-Leu-Aib)3-OMe (2) and its enantiomer Boc-(d-Leu-l-Leu-Aib)3-OMe (ent-2), four dodecapeptides, Boc-(l-Leu-d-Leu-Aib)4-OMe (3), Boc-(l-Leu-Aib-d-Leu)4-OMe (4), Boc-(Aib-l-Leu-d-Leu)4-OMe (5), and Boc-(l-Leu-Aib-d-Leu-Aib)3-OMe (6), and a decapeptide, Boc-l-Leu-(d-Leu-l-Leu-Aib)3-OMe (7), in solution and in the crystalline state. The nonapeptide 2 formed a right-handed (P) α-helix, and its enantiomer ent-2 formed a left-handed (M) α-helix. The dodecapeptides 3 and 5 were folded into (P) helices, and 4 formed an (M) helical structure. As for 6, roughly equivalent amounts of (P) and (M) helices were observed in solution, and two (M) α-helices were detected in the crystalline state. Furthermore, the decapeptide 7, which possesses four l-Leu residues and three d-Leu residues, was folded into an (M) α-helix.
Co-reporter:Yosuke Demizu, Saori Nagoya, Mitsunobu Doi, Yukiko Sato, Masakazu Tanaka, and Masaaki Kurihara
The Journal of Organic Chemistry 2012 Volume 77(Issue 20) pp:9361-9365
Publication Date(Web):September 24, 2012
DOI:10.1021/jo301509c
We designed and synthesized a C2-symmetric cyclic hexapeptide, cyclo(l-Leu-d-Leu-Aib)2 (2), which contains l- and d-amino acids and achiral Aib residues. The conformation of 2 was analyzed in the crystalline state and in solution, which was a unique figure-eight-shaped conformation.
Co-reporter:Yosuke Demizu, Mitsunobu Doi, Masaaki Kurihara, Haruhiro Okuda, Masanobu Nagano, Hiroshi Suemune and Masakazu Tanaka
Organic & Biomolecular Chemistry 2011 vol. 9(Issue 9) pp:3303-3312
Publication Date(Web):11 Mar 2011
DOI:10.1039/C0OB01146K
Four types of α,α-disubstituted amino acids {i.e., α-aminoisobutyric acid (Aib), 1-aminocyclopentanecarboxylic acid (Ac5c), (3S,4S)-1-amino-(3,4-dimethoxy)cyclopentanecarboxylic acid [(S,S)-Ac5cdOM] and its enantiomer (R,R)-Ac5cdOM} were introduced into L-leucine-based hexapeptides and nonapeptides. The dominant conformations of eight peptides: Cbz-(L-Leu-L-Leu-dAA)2-OMe [dAA = 1: Aib; 2: Ac5c; 3: (S,S)-Ac5cdOM; 4: (R,R)-Ac5cdOM] and Boc-(L-Leu-L-Leu-dAA)3-OMe [dAA = 5: Aib; 6: Ac5c; 7: (S,S)-Ac5cdOM; 8: (R,R)-Ac5cdOM], were investigated by IR, CD spectra and X-ray crystallographic analysis. The CD spectra revealed that Aib hexapeptide 1 and Ac5c hexapeptide 2 formed right-handed (P) 310-helices, while Ac5cdOM hexapeptides 3 and 4 formed a mixture of (P) 310- and α-helices. The Aib nonapeptide 5 formed a (P) 310-helix, the Ac5c nonapeptide 6 formed a mixture of (P) 310- and α-helices, and the Ac5cdOM nonapeptides 7 and 8 formed (P) α-helices. X-Ray crystallographic analysis revealed that the Aib hexapeptide 1 formed a (P) 310-helix, while (S,S)-Ac5cdOM hexapeptide 3 formed a (P) α-helix. In addition, the Ac5c nonapeptide 6 and (R,R)-Ac5cdOM nonapeptide 8 formed (P) α-helices. The Aib and achiral Ac5c residues have the propensity to form 310-helices in short peptides, whereas the chiral Ac5cdOM residues have a penchant for forming α-helices.
Co-reporter:Nanako Yamagata, Yosuke Demizu, Yukiko Sato, Mitsunobu Doi, Masakazu Tanaka, Kazuo Nagasawa, Haruhiro Okuda, Masaaki Kurihara
Tetrahedron Letters 2011 Volume 52(Issue 7) pp:798-801
Publication Date(Web):16 February 2011
DOI:10.1016/j.tetlet.2010.12.030
Stabilized short helical heptapeptides containing a combination of an α-aminoisobutyric acid as a helical promoter and l/d-serine derivatives to produce cross-linked units were synthesized. The cyclic peptide R3,7R-2, which had d-serine derivatives at its 3rd and 7th positions, formed a stable right-handed (P) α-helix in solution and the crystalline state. Furthermore, its N-terminal free helical peptide catalyzed the enantioselective epoxidation of (E)-chalcone to afford the epoxide in a high yield and moderate enantioselectivity.
Co-reporter:Yosuke Demizu, Nanako Yamagata, Saori Nagoya, Yukiko Sato, Mitsunobu Doi, Masakazu Tanaka, Kazuo Nagasawa, Haruhiro Okuda, Masaaki Kurihara
Tetrahedron 2011 67(34) pp: 6155-6165
Publication Date(Web):
DOI:10.1016/j.tet.2011.06.075
Co-reporter:Dr. Yosuke Demizu; Mitsunobu Doi;Yukiko Sato; Masakazu Tanaka;Dr. Haruhiro Okuda;Dr. Masaaki Kurihara
Chemistry - A European Journal 2011 Volume 17( Issue 40) pp:
Publication Date(Web):
DOI:10.1002/chem.201101809
Co-reporter:Makoto Oba, Yosuke Demizu, Nanako Yamagata, Yukiko Sato, Mitsunobu Doi, Masakazu Tanaka, Hiroshi Suemune, Haruhiro Okuda, Masaaki Kurihara
Tetrahedron 2010 66(13) pp: 2293-2296
Publication Date(Web):
DOI:10.1016/j.tet.2010.02.003
Co-reporter:Yosuke Demizu, Mitsunobu Doi, Yukiko Sato, Masakazu Tanaka, Haruhiro Okuda and Masaaki Kurihara
The Journal of Organic Chemistry 2010 Volume 75(Issue 15) pp:5234-5239
Publication Date(Web):July 16, 2010
DOI:10.1021/jo100965r
Three diastereomeric -Leu-Leu-Aib-Leu-Leu-Aib- peptides composed of the same numbers of l-Leu, d-Leu, and Aib residues were synthesized: Boc-l-Leu-l-Leu-Aib-d-Leu-d-Leu-Aib-OMe (1), Boc-l-Leu-d-Leu-Aib-l-Leu-d-Leu-Aib-OMe (2), and Boc-l-Leu-d-Leu-Aib-d-Leu-l-Leu-Aib-OMe (3). The crystals of the three peptides were characterized by X-ray crystallographic analysis as follows: (1) orthorhombic, P212121, a = 21.383 Å, b = 11.070 Å, c = 19.560 Å, Z = 4, R1 = 0.0527, and Rw = 0.1562; (2) monoclinic, P21, a = 9.391 Å, b = 21.278 Å, c = 11.662 Å, β = 99.125, Z = 2, R1 = 0.0507, and Rw = 0.1447; and (3) triclinic, P1, a = 12.545 Å, b = 14.913 Å, c = 15.330 Å, α = 77.622, β = 66.601, γ = 78.839, Z = 2, R1 = 0.0775, and Rw = 0.1971. The three diastereomeric peptides, 1, 2, and 3, showed unique conformations. That is to say, 1 was folded into a left-handed (M) 310-helical structure, 2 was folded into a distorted β-hairpin nucleated by a type II′ β-turn-like structure, and 3 was folded into an S-shape turn structure based on two type II/III β-turns.
Co-reporter:Hiroko Yamashita, Takashi Misawa, Makoto Oba, Masakazu Tanaka, Mikihiko Naito, Masaaki Kurihara, Yosuke Demizu
Bioorganic & Medicinal Chemistry (15 March 2017) Volume 25(Issue 6) pp:
Publication Date(Web):15 March 2017
DOI:10.1016/j.bmc.2017.01.044
Cell-penetrating peptides (CPP) have attracted many scientists’ attention as intracellular delivery tools due to their high cargo molecule transportation efficiency and low cytotoxicity. Therefore, in many research fields CPP, such as HIV-Tat and oligoarginine (Rn), are used to deliver hydrophilic drugs and biomolecules, including proteins, DNA, and RNA. We designed four types of CPP that contained cationic α,α-disubstituted amino acids (ApiC2Gu and ApiC4Gu) as helical promoters; i.e., 1–4 [FAM-β-Ala-(l-Arg-l-Arg-Xaa)3-(Gly)3-NH2 (1: Xaa = ApiC2Gu, 2: Xaa = ApiC4Gu), 3: FAM-β-Ala-(l-Arg)8-ApiC2Gu-(Gly)3-NH2, and 4: FAM-β-Ala-(l-Arg)5-ApiC2Gu-(l-Arg)2-ApiC2Gu-(Gly)3-NH2], and investigated their preferred secondary structures and cell membrane-penetrating ability. As a result, we found that the permeation efficiency of the CPP was affected by the number of helical promoters in their sequences. Specially, peptide 1, which contained three ApiC2Gu residues, formed a stable helical structure and passed through the cell membrane more efficiently than the other peptides. Moreover, it was demonstrated that the spatial arrangement of the peptides’ side chains also influenced their permeability and the helical stabilization of their main chains.
Co-reporter:Yosuke Demizu, Makoto Oba, Koyo Okitsu, Hiroko Yamashita, Takashi Misawa, Masakazu Tanaka, Masaaki Kurihara and Samuel H. Gellman
Organic & Biomolecular Chemistry 2015 - vol. 13(Issue 20) pp:NaN5620-5620
Publication Date(Web):2015/04/14
DOI:10.1039/C5OB00389J
A cyclic β-amino acid (APCGu) bearing a side-chain guanidinium group has been developed. The APCGu residue was incorporated into an α/β-peptide based on the Tat(47–57) fragment, leading to an oligomer with substantial helicity in methanol that enters HeLa cells much more readily than does the corresponding Tat α-peptide.
Co-reporter:Yosuke Demizu, Mitsunobu Doi, Masaaki Kurihara, Haruhiro Okuda, Masanobu Nagano, Hiroshi Suemune and Masakazu Tanaka
Organic & Biomolecular Chemistry 2011 - vol. 9(Issue 9) pp:NaN3312-3312
Publication Date(Web):2011/03/11
DOI:10.1039/C0OB01146K
Four types of α,α-disubstituted amino acids {i.e., α-aminoisobutyric acid (Aib), 1-aminocyclopentanecarboxylic acid (Ac5c), (3S,4S)-1-amino-(3,4-dimethoxy)cyclopentanecarboxylic acid [(S,S)-Ac5cdOM] and its enantiomer (R,R)-Ac5cdOM} were introduced into L-leucine-based hexapeptides and nonapeptides. The dominant conformations of eight peptides: Cbz-(L-Leu-L-Leu-dAA)2-OMe [dAA = 1: Aib; 2: Ac5c; 3: (S,S)-Ac5cdOM; 4: (R,R)-Ac5cdOM] and Boc-(L-Leu-L-Leu-dAA)3-OMe [dAA = 5: Aib; 6: Ac5c; 7: (S,S)-Ac5cdOM; 8: (R,R)-Ac5cdOM], were investigated by IR, CD spectra and X-ray crystallographic analysis. The CD spectra revealed that Aib hexapeptide 1 and Ac5c hexapeptide 2 formed right-handed (P) 310-helices, while Ac5cdOM hexapeptides 3 and 4 formed a mixture of (P) 310- and α-helices. The Aib nonapeptide 5 formed a (P) 310-helix, the Ac5c nonapeptide 6 formed a mixture of (P) 310- and α-helices, and the Ac5cdOM nonapeptides 7 and 8 formed (P) α-helices. X-Ray crystallographic analysis revealed that the Aib hexapeptide 1 formed a (P) 310-helix, while (S,S)-Ac5cdOM hexapeptide 3 formed a (P) α-helix. In addition, the Ac5c nonapeptide 6 and (R,R)-Ac5cdOM nonapeptide 8 formed (P) α-helices. The Aib and achiral Ac5c residues have the propensity to form 310-helices in short peptides, whereas the chiral Ac5cdOM residues have a penchant for forming α-helices.